Paediatric

Professor Richard Ross from the University of Sheffield explains in this video the problematics of children suffering from adrenal insufficiency...

Pediatric population is a sensitive sector of the healthcare and pharmaceutical field with additional needs compared to the adult population....

Oral pediatric formulations are either ready-to-use or require manipulation, and multi-use or single-use. Strong encouragement for preservative-free pediatric formulations has...

07. February 2017 INTRODUCTION: The pharmacokinetics of excipients in neonates differs from that of older children. In a recent pan--European...

16. January 2017 Introduction Palatability of liquid medicines is a recognised challenge within the paediatric population Acceptability: “The overall ability...

16. January 2017 INTRODUCTION Dissolution of oral dosage forms depends on the GI tract physiological conditions, and definition of the...

03. January 2017 Abstract Efavirenz (EFV), a non-nucleoside reverse transcriptase inhibitor (NNRTI), is part of first-line therapy for the treatment...

24. August 2016 Pediatric Medicines Are Not Child’s Play! AAPS Blog Since the introduction of pediatric regulations in the USA (Pediatric...

11. August 2016 Many pediatric patients require medications that are not available in age appropriate formulations, especially those with cardiovascular...

25. February 2016 The STEP stands for Safety and Toxicity of Excipients for Paediatrics. It is a user-designed resource developed by European Paediatric Formulation...